BeiGene announced that the cumulative deviation of the closing price of the company's stock from the market value for three consecutive trading days from August 28, 2025, to September 1, 2025, exceeded 30%, constituting abnormal stock trading fluctuations. The company's self-inspection confirmed that production and operations are currently operating normally, with no significant changes and no undisclosed material information. Furthermore, the company's stock price has experienced significant short-term fluctuations, and investors are reminded to be aware of investment risks and exercise rational decision-making and prudence.